Free Trial

CochLear Ltd. Unsponsored ADR Declares Dividend of $0.10 (OTCMKTS:CHEOY)

CochLear logo with Medical background

Key Points

  • CochLear Ltd. Unsponsored ADR has announced a dividend of $0.10 per share, with stockholders of record on September 22nd set to receive it on October 28th.
  • The stock is currently showing a dividend yield of 122.0%, with an ex-dividend date of September 19th.
  • Cochlear Limited specializes in implantable hearing solutions and has seen stock prices range from a twelve-month low of $74.76 to a high of $105.60.
  • MarketBeat previews the top five stocks to own by October 1st.

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY - Get Free Report) declared a dividend on Tuesday, September 16th, investing.com reports. Stockholders of record on Monday, September 22nd will be given a dividend of 0.1045 per share on Tuesday, October 28th. This represents a dividend yield of 122.0%. The ex-dividend date of this dividend is Friday, September 19th.

CochLear Price Performance

CochLear stock opened at $101.66 on Tuesday. CochLear has a twelve month low of $74.76 and a twelve month high of $105.60. The firm has a 50 day moving average price of $99.69 and a 200-day moving average price of $91.30.

About CochLear

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

See Also

Dividend History for CochLear (OTCMKTS:CHEOY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CochLear Right Now?

Before you consider CochLear, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.

While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.